1-3 of 3
Micheline Piquette-Miller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer

Available to Purchase
Raquel De Souza, Payam Zahedi, Rose M. Badame, Christine Allen, Micheline Piquette-Miller
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (7): 1289–1299.
https://doi.org/10.1158/1535-7163.MCT-11-0058
Published: 06 July 2011
View articletitled, Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer
Open the PDF for Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer

Available to Purchase
Raquel De Souza, Payam Zahedi, Eduardo H. Moriyama, Christine J. Allen, Brian C. Wilson, Micheline Piquette-Miller
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1820–1830.
https://doi.org/10.1158/1535-7163.MCT-10-0249
Published: 09 June 2010
View articletitled, Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer
Open the PDF for Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer

Available to Purchase
Vessela Vassileva, Christine J. Allen, Micheline Piquette-Miller
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (3): 630–637.
https://doi.org/10.1158/1535-7163.MCT-07-2117
Published: 17 March 2008
View articletitled, Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer
Open the PDF for Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer in another window